Acquisition / mergerFiled on NSE ·

Pramodini Medicare Ltd reports Q2 FY27 financials and IPO fund utilization

Pramodini Medicare · Healthcare Services

Arthneeti Research DeskPublished 1 min read
₹69 CrAcquisition / merger

Key highlights

  • Approved unaudited standalone and consolidated financial results for half-year ended Sept 30, 2026.
  • IPO proceeds raised ₹69.04 crore in Aug 2026; ₹20 crore utilized by Sept 30, 2026; ₹36.03 crore unutilized and invested in fixed deposits.
  • Constituted ESOP committee with 4 members including Managing Director and 3 Independent Directors.

Original filing

Outcome of Board Meeting

Read the filing on NSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Pramodini Medicare

Other acquisition / merger filings this fortnight

All acquisition / merger filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.